The report “Global Clinical Trial Supplies Market, By Global Clinical Trial Supplies Market, By Phases (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Interventional Trails, Observational Trials, and Expanded Access Trials), By Application (Oncology, CNS, Cardiovascular, Infectious Disease, Metabolic Disorders, and Others), By End-user (Contract Research Organizations, Pharmaceutical & BioStudy Design Companies, Research Institutes, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Trends, Analysis and Forecast till 2025”.
Key Highlights:
- In December 2019, PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, declared the completion of an expansion to its Rockford, IL facility to improve its specialty drug product capabilities.
- On February 2020, PAREXEL International Corporation, an innovative provider of solutions to enhance the development and delivery of innovative new therapies to improve world health, from Clinical through Commercialization, declared that it has completed the acquisition of Model Answers, a consultancy firm based in Brisbane, Queensland, Australia. Model Answers provides pharmacodynamic (PD) and pharmacokinetic (PK) modeling, analysis, and simulation services to customers in the life sciences industry to help increase the likelihood of successful drug development.
Key Market Insights from the report:
The global clinical trial supplies market accounted for US$ 1.7 billion in 2020 and is estimated to be US$ 2.5 billion by 2025 and is anticipated to register a CAGR of 7.8%. The market report has been segmented on the basis of phases, study design, application, end-user, and region.
- By phases, phase III is expected to be dominated the segment over the forecast period. The presence of large number of molecule accounted to reach Phase III by 2020 is the main factor answerable for this prediction.
- By study design, interventional trails segment is expected to dominate the target market owing to evolutions and innovations in the treatment
- By application, Oncology segment is dominating the global market owing to increasing number of patients suffering from various diseases
- By end-user, Contract Research Organizations segment is dominating the global market owing to increasing R&D activities
- By region, North America is the chief regional market for clinical trial supplies, followed by Europe. This is mainly attributed owing to the presence of well-established biopharmaceutical companies and CROs.
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Clinical-Trial-Supplies-Market-4222
Competitive Landscape:
The prominent player operating in the global clinical trial supplies market includes PAREXEL International Corporation, KLIFO A/S, Almac Group Ltd., Patheon Inc., Biocair International Ltd., Movianto GmbH, Sharp Packaging Services, PCI Services, Thermo Fischer Scientific, and Catalent Pharma Solutions.
The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report.
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.com
